Topic: Pharmacogenomics and Pharmacogenetics of Cancer
Contents
Chair
Prof. Enrico Mini
Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
Speaker(s)
Dr. Stefania Nobili
Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Topic: Pharmacogenetics in diffuse large B cell lymphomas
Topic: Pharmacogenetics in diffuse large B cell lymphomas
Prof. Ingolf Cascorbi
Department of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Topic: Germline pharmacogenetics in cancer therapy
Topic: Germline pharmacogenetics in cancer therapy
Dr. Erika Cecchin
Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Topic: DPYD pharmacogenetics to prevent fluoropyrimidines toxicity: Where do we stand?
Topic: DPYD pharmacogenetics to prevent fluoropyrimidines toxicity: Where do we stand?
Prof. Giuseppe Curigliano
Istituto Europeo di Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico, University of Milano, Milan, Italy.
Topic: Biomarkers to predict response to ADCs (Antibody Drug Conjugates)
Topic: Biomarkers to predict response to ADCs (Antibody Drug Conjugates)
Programme
Programme
| Time | Chair / Speakers | Topic | |
| GMT+2 | GMT-4 | ||
| 13:00 - 13:10 | 7:00-7:10 | Enrico Mini | Welcoming Address |
| 13:10 - 13:30 | 7:10 - 7:30 | Ingolf Cascorbi | Germline pharmacogenetics in cancer therapy |
| 13:30 - 13:50 | 7:30 - 7:50 | Erika Cecchin | DPYD pharmacogenetics to prevent fluoropyrimidines toxicity: where do we stand? |
| 13:50 - 14:10 | 7:50 - 8:10 | Stefania Nobili | Pharmacogenetics in diffuse large B cell lymphomas |
| 14:10 - 14:30 | 8:10 - 8:30 | Giuseppe Curigliano | Biomarkers to predict response to ADCs (Antibody Drug Conjugates) |
| 14:30 - 15:00 | 8:30 - 9:00 | Enrico Mini | Q&A |
| 15:00 - 15:10 | 9:00 - 9:10 | Enrico Mini | Conclusion |
Moments
Presentation
Prof. Ingolf Cascorbi
Topic: Germline pharmacogenetics in cancer therapy
NaN
Prof. Giuseppe Curigliano
Topic: Biomarkers to predict response to ADCs (Antibody Drug Conjugates)
NaN
